Arulselvan P, Senthilkumar G P, Sathish Kumar D, Subramanian S
Department of Biochemistry and Molecular Biology, University of Madras, Chennai, Tamil Nadu, India.
Pharmazie. 2006 Oct;61(10):874-7.
The present study was aimed to evaluate the anti-hyperglycemic efficacy of Murraya koenigii in STZ-induced diabetic rats. Oral administration of ethanolic extract of M. koenigii at a dose of 200 mg/kg/ b.w./day for a period of 30 days significantly decreased the levels of blood glucose, glycosylated hemoglobin, urea, uric acid and creatinine in diabetic treated group of animals. Determination of plasma insulin level revealed the insulin stimulatory effect of the extract. The results suggest that M. koenigii possesses statistically significant hypoglycemic potential in STZ-induced diabetic rats. The M. koenigii extract appeared to be more effective than glibenclamide, a known antidiabetic drug.
本研究旨在评估九里香对链脲佐菌素诱导的糖尿病大鼠的降血糖功效。以200毫克/千克体重/天的剂量口服给予九里香乙醇提取物,持续30天,显著降低了糖尿病治疗组动物的血糖、糖化血红蛋白、尿素、尿酸和肌酐水平。血浆胰岛素水平测定显示该提取物具有胰岛素刺激作用。结果表明,九里香对链脲佐菌素诱导的糖尿病大鼠具有统计学上显著的降血糖潜力。九里香提取物似乎比已知的抗糖尿病药物格列本脲更有效。